About the journal
Cancer Immunology, Immunotherapy is an open-access journal published by Springer in Germany, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 3,590 EUR. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer
- ISSN
- 0340-7004 · 1432-0851
- Country
- Germany
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,590 EUR
- Articles in DOAJ
- 605
- Declared review time
- 14 weeks
- Declared peer-review model
- peer_review
- Official website
- https://link.springer.com/journal/262
Index listings
- DOAJ · 2024-12-04
- MEDLINE · 1982-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 3,590 EUR
- Declared review time (DOAJ)
- 14 weeks
- Actual review time (measured)
- 108 days received→accepted — computed from PubMed (n=91)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
605
Most recent article
last month
Average review time (journal-declared via DOAJ)
14weeks
Works in OpenAlex
7610
Last recorded publication year
2026
h-index
164
i10-index
4893
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2024-12-04
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 85%
- ORCID iDs in current deposits
- 18%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- Cancer immunology, immunotherapy (PrintCII. Cancer immunology and immunotherapy
- Source type
- journal
- NLM unique ID (PubMed)
- 8605732
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- CAR-T cell therapy research
Show all subjects (50)
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Immune cells in cancer
- Immune cells in cancer
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Virus-based gene therapy research
- Immune Response and Inflammation
- Virus-based gene therapy research
- Immune Response and Inflammation
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Cancer Research and Treatments
- Cancer Research and Treatments
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Cancer Cells and Metastasis
- Ferroptosis and cancer prognosis
- Cancer Cells and Metastasis
- Ferroptosis and cancer prognosis
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- Chemokine receptors and signaling
- Chemokine receptors and signaling
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Cancer, Stress, Anesthesia, and Immune Response
- Inflammatory Biomarkers in Disease Prognosis
- Cancer, Stress, Anesthesia, and Immune Response
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Keywords (DOAJ)
- oncology
- cancer biology
- tumor immunology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ